Skip to main content

and
  1. No Access

    Article

    SDHB large deletions are associated with absence of MIBG uptake in metastatic lesions of malignant paragangliomas

    Janaina Petenuci, Gustavo F. C. Fagundes, Anna Flavia F. Benedetti in Endocrine (2021)

  2. Article

    5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma

    Adrenocortical carcinoma (ACC) is a rare and complex disease associated with a high mortality rate. Despite intensive translational and clinical research, prognosis remains poor. Over the past decade, a signif...

    Ana O. Hoff, Alfredo Berruti in Hormones and Cancer (2016)

  3. Article

    Open Access

    A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers

    Patients with advanced endocrine cancers, such as adrenocortical carcinoma and medullary thyroid carcinoma, have few well-validated therapeutic options. Pre-clinical studies have suggested potential activity o...

    Daniel M Halperin, Alexandria T Phan, Ana O Hoff, Marie Aaron, James C Yao in BMC Cancer (2014)

  4. No Access

    Book

  5. No Access

    Chapter

    Hereditary and Sporadic Medullary Thyroid Carcinoma

    Medullary thyroid carcinoma (MTC) is an uncommon neuroendocrine tumor that arises from the parafollicular cells of the thyroid gland. These cells ­produce calcitonin, a peptide that is a useful marker of disea...

    Ana O. Hoff, Cleber Camacho MD, Rui M. B. Maciel in Neuroendocrine Tumors (2011)